CA1004597A - Pharmaceutical compositions containing 7-bromo-1,3-dihydro-5-(2-pyridyl)-2h-1,4- benzodiazepin-2-one and n-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulphamoylbenzamide - Google Patents
Pharmaceutical compositions containing 7-bromo-1,3-dihydro-5-(2-pyridyl)-2h-1,4- benzodiazepin-2-one and n-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulphamoylbenzamideInfo
- Publication number
- CA1004597A CA1004597A CA181,513A CA181513A CA1004597A CA 1004597 A CA1004597 A CA 1004597A CA 181513 A CA181513 A CA 181513A CA 1004597 A CA1004597 A CA 1004597A
- Authority
- CA
- Canada
- Prior art keywords
- sulphamoylbenzamide
- benzodiazepin
- pyrrolidinyl
- pyridyl
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- VMIYHDSEFNYJSL-UHFFFAOYSA-N Bromazepam Chemical compound C12=CC(Br)=CC=C2NC(=O)CN=C1C1=CC=CC=N1 VMIYHDSEFNYJSL-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1380572 | 1972-09-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1004597A true CA1004597A (en) | 1977-02-01 |
Family
ID=4395499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA181,513A Expired CA1004597A (en) | 1972-09-21 | 1973-09-20 | Pharmaceutical compositions containing 7-bromo-1,3-dihydro-5-(2-pyridyl)-2h-1,4- benzodiazepin-2-one and n-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulphamoylbenzamide |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US3864486A (en:Method) |
| AU (1) | AU471785B2 (en:Method) |
| BE (1) | BE805055A (en:Method) |
| CA (1) | CA1004597A (en:Method) |
| DD (1) | DD113438A5 (en:Method) |
| DE (1) | DE2342214C3 (en:Method) |
| ES (1) | ES418931A1 (en:Method) |
| FR (1) | FR2199992B1 (en:Method) |
| GB (1) | GB1393226A (en:Method) |
| IL (1) | IL43030A0 (en:Method) |
| LU (1) | LU68442A1 (en:Method) |
| NL (1) | NL177279C (en:Method) |
| SE (1) | SE423594B (en:Method) |
| ZA (1) | ZA735524B (en:Method) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4316897A (en) * | 1980-09-10 | 1982-02-23 | Hoffmann-La Roche Inc. | Method of lowering serum prolactin |
| FR2586018B1 (fr) * | 1985-08-12 | 1988-03-25 | Ile De France | Nouveau benzodioxepanne, son procede de synthese et ses applications en therapeutique |
| BR9802915A (pt) * | 1997-09-12 | 2000-01-11 | Oscar Gold | Procedimento para formar composições farmaceuticas em pilulas ou granulos substancialmente esfericos, de ação controlada e continuada, contendo como agente ativo o (7-bromo-1,3-diidro-5-(2-piridninilo)-2h-1,4-benzodiazep ina-2(1h)-um) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR6834M (en:Method) * | 1967-11-22 | 1969-03-31 | ||
| FR6833M (en:Method) * | 1967-11-22 | 1969-03-31 |
-
1973
- 1973-08-13 ZA ZA735524A patent/ZA735524B/xx unknown
- 1973-08-20 IL IL43030A patent/IL43030A0/xx unknown
- 1973-08-21 DE DE2342214A patent/DE2342214C3/de not_active Expired
- 1973-08-21 AU AU59447/73A patent/AU471785B2/en not_active Expired
- 1973-09-07 NL NLAANVRAGE7312363,A patent/NL177279C/xx not_active IP Right Cessation
- 1973-09-12 US US396651A patent/US3864486A/en not_active Expired - Lifetime
- 1973-09-18 LU LU68442A patent/LU68442A1/xx unknown
- 1973-09-19 SE SE7312768A patent/SE423594B/xx unknown
- 1973-09-20 GB GB4418373A patent/GB1393226A/en not_active Expired
- 1973-09-20 CA CA181,513A patent/CA1004597A/en not_active Expired
- 1973-09-20 ES ES418931A patent/ES418931A1/es not_active Expired
- 1973-09-20 FR FR7333717A patent/FR2199992B1/fr not_active Expired
- 1973-09-20 BE BE135815A patent/BE805055A/xx not_active IP Right Cessation
- 1973-09-20 DD DD173623A patent/DD113438A5/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU5944773A (en) | 1975-02-27 |
| FR2199992B1 (en:Method) | 1977-01-28 |
| DD113438A5 (en:Method) | 1975-06-12 |
| AU471785B2 (en) | 1976-05-06 |
| NL7312363A (en:Method) | 1974-03-25 |
| GB1393226A (en) | 1975-05-07 |
| ES418931A1 (es) | 1976-11-16 |
| SE423594B (sv) | 1982-05-17 |
| LU68442A1 (en:Method) | 1975-05-21 |
| US3864486A (en) | 1975-02-04 |
| ZA735524B (en) | 1974-07-31 |
| BE805055A (fr) | 1974-03-20 |
| FR2199992A1 (en:Method) | 1974-04-19 |
| DE2342214A1 (de) | 1974-03-28 |
| NL177279B (nl) | 1985-04-01 |
| DE2342214C3 (de) | 1981-12-03 |
| DE2342214B2 (de) | 1980-10-23 |
| IL43030A0 (en) | 1973-11-28 |
| NL177279C (nl) | 1985-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL42158A (en) | 5-phenyl-2-substituted methyl-2,3-dihydro-1h-1,4-benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them | |
| NO812224L (no) | Pustedrevet anordning for administrering av pulverformige medikamenter. | |
| FI803767A7 (fi) | Kortikosteroidia sisältäviä farmaseuttisia seoksia. | |
| NL300015I2 (nl) | 1,3-Dihydro-4-(aroyl)-2H-imidazool-2-onen en anti-hypertensief, cardiotoon en anti-trombotisch werkzaam farmaceutisch preparaat. | |
| PH9997A (en) | Pharmacologically active n(1h-tetrazol-5-yl)quinaldamide compounds and compositions containing them | |
| DE3868283D1 (de) | Anthrachinonverbindungen und polarisierender film, der solche enthaelt. | |
| CA1004597A (en) | Pharmaceutical compositions containing 7-bromo-1,3-dihydro-5-(2-pyridyl)-2h-1,4- benzodiazepin-2-one and n-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulphamoylbenzamide | |
| FR2368474B1 (fr) | Lactames n-substitues et compositions pharmaceutiques en renfermant | |
| IL41259A0 (en) | Isoindoline derivatives,processes for their preparation and pharmaceutical compositions containing the same | |
| IL49563A0 (en) | Pharmaceutical compositions comprising a diaminopyrimidine,a sulphamide and amylase | |
| NZ182263A (en) | 2-carboxyalkyl-4,4-dimethyl-1-hydroxy-alkyl-pyrrolidin-3,5-dione derivativesand pharmaceutical compositions | |
| PT65544B (de) | Substituierte sulfoximide verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| FI52343C (fi) | Menetelmä 3-hydroksi-1,3-dihydro-2H-1,4-bentsodiatsepiini-2-oni-yhdist eiden mikrobiologiseksi valmistamiseksi | |
| NL146163B (nl) | Werkwijze voor het bereiden van therapeutisch werkzame 2,3,4,5-tetrahydro 1,4-benzoxazepinederivaten. | |
| PH12135A (en) | Anthelmintic pharmaceutical preparations containing 4-(4-nitroanilino)-phenylisothiocyanate | |
| IL39337A (en) | 2-(pyridazinyl)-3-(4-methyl-piperazin-4-yl)carbonyloxy-isoindolin-1-one derivatives,processes for their preparation and pharmaceutical compositions containing the same | |
| IL37609A0 (en) | Novel benzodiazepine derivatives,processes for their preparation and pharmaceutical compositions containing the same | |
| NL7613606A (nl) | Werkwijze voor het bereiden van nieuwe (beta)-lactam verbindingen, alsmede deze verbindingen bevat- tende farmaceutische preparaten. | |
| CA943462A (en) | Pharmaceutical compositions containing 2-(2,6-dichlorophenyl-amino)-1,3-diazacyclopentene-(2) | |
| CA980163A (en) | Photocrosslinkable compositions and elements containing heterocyclic nitrogen-containing compounds | |
| IL26928A (en) | Pharmaceutical compositions containing 7-chloro-2-methylamino-5-phenyl-3h-1,4-benzodiazepine 4-oxide and 5-(3-dimethylamino-propylidene)-dibezo(a,d)-(1,4)cycloheptadiene | |
| IL42179A0 (en) | Cyclopentenoquinolone derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| CA1017357A (en) | N-(triaryl-methyl)-amidines, process for the preparation thereof and compositions containing the same | |
| PH9370A (en) | 15a,16a-methylene-4-oestran-17b-ols and pharmaceutical compositions thereof | |
| PH9489A (en) | N'-(1,2-dihydro-2-oxo-4-pyrimidenyl)sulfanilamides and pharmaceutical compositions containing them |